Pre-Operative Plasma Extracellular Vesicle Proteins are Associated with a High Risk of Long Term Secondary Major Cardiovascular Events in Patients Undergoing Carotid Endarterectomy

Abstract

WHAT THIS PAPER ADDSPatients treated by carotid endarterectomy (CEA) remain at high risk of future major cardiovascular events (MACE), although this risk varies substantially between individuals. With emerging novel options to intensify medical treatment, risk stratification for MACE is warranted. This study has demonstrated that pre-operative levels of four proteins (CD14, cystatin C, serpin C1, and serpin F2) in plasma extracellular vesicles (EVs) were positively associated with increased risks of MACE after CEA. EV-CD14 improved risk stratification for MACE on top of cardiovascular risk factors. Thus, EV-CD14 may be a useful marker to select high risk patients that qualify for intensified medical treatment.Objective: Patients undergoing carotid endarterectomy (CEA) maintain a substantial residual risk of major cardiovascular events (MACE). Improved risk stratification is warranted to select high risk patients qualifying for secondary add on therapy. Plasma extracellular vesicles (EVs) are involved in atherothrombotic processes and their content has been related to the presence and recurrence of cardiovascular events. The association between pre-operative levels of five cardiovascular disease related proteins in plasma EVs and the postoperative risk of MACE was assessed. Methods: In 864 patients undergoing CEA from 2002 to 2016 included in the Athero-Express biobank, three plasma EV subfractions (low density lipoprotein [LDL], high density lipoprotein [HDL], and tiny extracellular vesicles [TEX]) were isolated from pre-operative blood samples. Using an electrochemiluminescence immunoassay, five proteins were quantified in each EV subfraction: cystatin C, serpin C1, serpin G1, serpin F2, and CD14. The association between EV protein levels and the three year post-operative risk of MACE (any stroke, myocardial infarction, or cardiovascular death) was evaluated using multivariable Cox proportional hazard regression analyses. Results: During a median follow up of three years (interquartile range 2.2 e 3.0), 137 (16%) patients developed MACE. In the HDL-EV subfraction, increased levels of CD14, cystatin C, serpin F2, and serpin C1 were associated with an increased risk of MACE (adjusted hazard ratios per one standard deviation increase of 1.30, 95% confidence interval [CI] 1.15e1.48; 1.22, 95% CI 1.06e1.42; 1.36, 95% CI 1.16e1.61; and 1.29, 95% CI 1.10e 1.51; respectively), independently of cardiovascular risk factors. No significant associations were found for serpin G1. CD14 improved the predictive value of the clinical model encompassing cardiovascular risk factors (net re-classification index ¼ 0.16, 95% CI 0.08e0.21). Conclusion: EV derived pre-operative plasma levels of cystatin C, serpin C1, CD14, and serpin F2 were independently associated with an increased long term risk of MACE after CEA and are thus markers for residual cardiovascular risk. EV derived CD14 levels could improve the identification of high risk patients who may benefit from secondary preventive add on therapy in order to reduce future risk of...

Metabolomics data improve 10-year cardiovascular risk prediction with the SCORE2 algorithm for the general population without cardiovascular disease or diabetes

“…42 Lipoprotein components, such as IDL-CE-pct and L-VLDL-TG-pct, represent the intricate dynamics of lipid content and particle size within lipoprotein subclasses, which are crucial in the development and progression of atherosclerosis. [43][44][45][46]…”

Role of Extracellular Vesicles in Cardiac Regeneration

“…Plasma EV proteins cystatin C, serpin C1, CD14, and serpin F2 levels are associated with an increased long-term major cardiovascular event risk after carotid endarterectomy suggesting cardiovascular risk markers [70].…”

Impact of Controlling Nutritional Status score on short-term outcomes after carotid endarterectomy: a retrospective cohort study

“…However, the benefits of CEA shown in previous studies may be limited at any time because of the development of perioperative complications that are influenced by patient-related factors. Indeed, patients undergoing CEA have a residual risk of future stroke or major cardiovascular events owing to the systemic nature of atherosclerosis [ 4 ]. The cause of this increased risk of postoperative complications in patients with CEA is unclear.…”

“…Malnutrition and immune responses are involved in the atherosclerotic process; their content is associated with the recurrence of stroke or cardiovascular events and is an important cause of postoperative complications in various surgeries [ 4 , 5 ]. Therefore, malnutrition-immune data may be necessary for categorizing risk and understanding the residual risk in patients undergoing CEA.…”